Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.
Hadjigeorgiou GM, Doxani C, Miligkos M, Ziakas P, Bakalos G, Papadimitriou D, Mprotsis T, Grigoriadis N, Zintzaras E. Hadjigeorgiou GM, et al. Among authors: bakalos g. J Clin Pharm Ther. 2013 Dec;38(6):433-9. doi: 10.1111/jcpt.12090. Epub 2013 Aug 20. J Clin Pharm Ther. 2013. PMID: 23957759 Review.
Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate-gene association study in a South-eastern European population.
Papandreou CN, Doxani C, Zdoukopoulos N, Vlachostergios PJ, Hatzidaki E, Bakalos G, Ziogas DC, Koufakis T, Zintzaras E. Papandreou CN, et al. Among authors: bakalos g. DNA Cell Biol. 2012 Feb;31(2):193-8. doi: 10.1089/dna.2011.1292. Epub 2011 Aug 29. DNA Cell Biol. 2012. PMID: 21875371
Comparative immunogenicity assessment of biosimilars.
Schreitmüller T, Barton B, Zharkov A, Bakalos G. Schreitmüller T, et al. Among authors: bakalos g. Future Oncol. 2019 Jan;15(3):319-329. doi: 10.2217/fon-2018-0553. Epub 2018 Oct 3. Future Oncol. 2019. PMID: 30278780 Review.
Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International Cohort Studies.
Asselah T, Esmat G, Sanai FM, Goulis I, Messinger D, Bakalos G, Waked I. Asselah T, et al. Among authors: bakalos g. Adv Ther. 2016 Oct;33(10):1797-1813. doi: 10.1007/s12325-016-0396-4. Epub 2016 Aug 12. Adv Ther. 2016. PMID: 27517563 Clinical Trial.
22 results